COSMXPriority claimed from 05/08/2021; Application No. : 90/867,023 ;United States of America (Class 1)

The trademark application number 5249960 is owned by NanoString Technologies, Inc..

Trademark application number 5249960 is filed under Class 1, which relates to the specified goods and services.

The trademark agent associated with application number 5249960 is FIDUS LAW CHAMBERS.

Yes, trademark application number 5249960 was published in Journal No. 2146.

Trademark application number 5249960 relates to "reagents and instruments for scientific, research or non-medical or veterinary diagnostic use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for scientific or research use in the fields of cancer, neurology and infectious disease; reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for scientific, research or non-medical or veterinary diagnostic use containing antibodies and nucleic acids; reagent kits comprising primarily reagents for scientific, research or non-medical or veterinary diagnostic use in the fields of cancer, neurology and infectious disease; reagents for immuno-histochemistry detection and in situ-hybridization detection for scientific, research or non-medical or veterinary diagnostic use; test kits for scientific, research or non-medical or veterinary diagnostic use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; test kits comprising reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for in vitro use in clinical chemistry and molecular biology; reagents for clinical or medical laboratory use, namely, reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling, nucleic acid sequencing, and clinical, oncology, neurology, and infectious disease diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers;".